MIRA INFORM REPORT
|
Report Date : |
19.02.2011 |
IDENTIFICATION DETAILS
|
Name : |
NIPPON GENETICS CO LTD |
|
|
|
|
Registered Office : |
Hongo Tsuna Bldg, 6-17-9 Hongo Bunkyoku |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Date of Incorporation : |
November 1988 |
|
|
|
|
Com. Reg. No.: |
(Tokyo-Bunkyoku) 005867 |
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
Line of Business : |
Import, wholesale
of research/laboratory equipment & supplies |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
Yen 11.5 Million |
|
|
|
|
Status : |
Small Company |
|
|
|
|
Payment
Behaviour : |
Regular |
|
|
|
|
Litigation : |
---- |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2010
|
Country Name |
Previous Rating (01.04.2010) |
Current Rating (30.06.2010) |
|
|
a1 |
a1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name
NIPPON GENETICS CO LTD
REGD NAME
MAIN OFFICE
Hongo Tsuna Bldg, 6-17-9
Hongo Bunkyoku
Tel:
03-3813-0961 Fax: 03-3813-0962
URL: http//:www.n-genetics.co.jp
E-mail: info@n-genetics.co.jp
ACTIVITIES
Import,
wholesale of research/laboratory equipment & supplies
BRANCHES
OVERSEAS
OFFICER(S)
KAZUO
YAMAZAKI, PRES Tomoyuki Araki, v
pres
Masaaki
Hashimoto, mgn dir Kazunori Sato,
mgn dir
Naoki Taguchi, dir
Yen
Amount: In million Yen, unless
otherwise stated
SUMMARY
FINANCES FAIR A/SALES Yen 1,792 M
PAYMENTS REGULAR CAPITAL Yen 10 M
TREND STEADY WORTH Yen
136 M
STARTED 1988 EMPLOYES 25
COMMENT
IMPORTER OF LABORATORY/RESEARCH EQUIPMENT & SUPPLIES.
FINANCIAL SITUATION CONSIDERED
FAIR AND GOOD FOR ORDINARY BUSINESS ENGAGEMENTS
MAX
CREDIT LIMIT: YEN 11.5 MILLION, 30 DAYS NORMAL TERMS
HIGHLIGHTS
The subject company was established by Kazuo Yamazaki in
order to make most of his experience in the subject line of business. This is a trading firm specializing in importing
and wholesaling research-grade liquid handling product, equipment &
supplies (See OPERATION). Goods are imported from
FINANCIAL INFORMATION
The sales volume for Dec/2009 fiscal term amounted to Yen 1,792 million, a 9% up, as adjusted on a 12-month basis, from Yen 546 million for irregular 4 months in the previous term. The operations came back to profitability. The recurring profit was posted at Yen 33 million and the net profit at Yen 14 million, respectively, compared with Yen 31 million recurring loss and Yen 33 million net losses, respectively, a year ago. .
For the term that ended Dec 2010 the recurring profit was projected at Yen 35 million and the net profit at yen 15 million, respectively, on a 9% rise in turnover, to Yen 1,950 million. Final results are yet to be released.
The financial situation is considered FAIR and good for ORDINARY business engagements. Max credit limit is estimated at Yen 11.5 million, on 30 days normal terms.
REGISTRATION
Date Registered: Nov 1988
Regd No.: (Tokyo-Bunkyoku) 005867
Legal Status: Limited
Company (Kabushiki Kaisha)
Authorized: 800
shares
Issued: 200
shares
Sum: Yen 10 million
Major shareholders (%):
Kazuo Yamazaki (95), Mie Yamazaki (5)
No. of shareholders: 2
Nothing
detrimental is known as to the commercial morality of executives.
OPERATION
Activities: Imports and wholesales research-grade liquid handling products: micro-pipette tips, tubes, plastic disposables, cell culture slide chamber, laboratory gloves, PCR reagents, laboratory equipment, tools, PCR thermal cyclers, other (--100%)
Clients: [Mfrs, laboratories, research centers] Seiko Co, Ikeda Scientific Co, Wakenyaku Co, Shimada Machinery, RIKEN Japan, Frontier Science, other
No. of accounts: 300
Domestic areas of activities: Nationwide
Suppliers: [Mfrs, wholesalers] Sorensen TM Bio Science, ibidi GmbH, ANSELL Healthcare Japan, Bioline Labs Ltd, Major Science, VWR International Inc, other.
Payment record: Regular
Location:
Business area in
Bank References:
Asahi
Shinkin Bank (Yushima)
Mizuho
Bank (Hongo)
Relations:
Satisfactory
FINANCES
(In Million Yen)
|
Terms Ending: |
31/12/2010 |
31/12/2009 |
31/12/2008 |
31/08/2007 |
|
|
Annual
Sales |
|
1,950 |
1,792 |
546 |
1,694 |
|
Recur.
Profit |
|
35 |
33 |
-31 |
|
|
Net
Profit |
|
15 |
14 |
-33 |
11 |
|
Total
Assets |
|
|
1,343 |
1,376 |
1,220 |
|
Current
Assets |
|
|
890 |
1,085 |
|
|
Current
Liabs |
|
|
680 |
822 |
|
|
Net
Worth |
|
|
136 |
121 |
166 |
|
Capital,
Paid-Up |
|
|
10 |
10 |
10 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
8.82 |
9.40 |
-3.30 |
0.18 |
|
|
Current Ratio |
|
.. |
130.88 |
132.00 |
.. |
|
N.Worth Ratio |
.. |
10.13 |
8.79 |
13.61 |
|
|
R.Profit/Sales |
|
1.79 |
1.84 |
-5.68 |
.. |
|
N.Profit/Sales |
0.77 |
0.78 |
-6.04 |
0.65 |
|
|
Return On Equity |
.. |
10.29 |
-27.27 |
6.63 |
|
Notes: The 31/12/2008 fiscal term is for irregular 4 months
due to change in accounting term to Jan/Dec from Sept/Aug. The growth rates are adjusted on a 12-month
basis.
Forecast
(or estimated) figures for the 31/12/2010 fiscal term.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.18 |
|
|
1 |
Rs.73.04 |
|
Euro |
1 |
Rs.61.43 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.